Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

Hapvida buys another rival

HMO Hapvida is cementing its presence in Southern Brazil with the acquisition of another rival, its third takeover this year.
July 22, 2019

Dasa opens largest genetic testing centre in LATAM

Brazil's biggest lab company Dasa has said it expects its genetic testing subsidiary to be worth more than its core routine testing business within ten years as it opens LATAM's "largest" sequencing facility.
July 4, 2019

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 
July 3, 2019

Hapvida acquires second rival this year

Brazilian HMO Hapvida has acquired smaller rival Grupo América as it rolls its expansion strategy out across the country. HBI talks to a market source to find out more.
June 20, 2019

Opportunities in LATAM

Panellists on the LatAm panel at HBI 2019 see good opportunities in the region thanks to booming demand, particularly as demographics shift from rural to urban bases, and with the growth of the chronic and elderly care markets. Increasing use of digital health tools and better data, plus the growth of the consumer market are also seen as positive factors for the market.
May 28, 2019

DocPlanner flying towards Unicorn status

DocPlanner, the online booking and rating platform rival to Doctolib, has just closed a Series E funding round for €80m, but the company says it has "some way to go" to unicorn status. 
May 15, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us